Catalent to Sell Commercial Packaging Operations
Catalent Pharma Solutions recently signed a definitive agreement to sell its
The transaction does not involve Catalent’s Clinical Supply Services operations in
Catalent’s decision to sell its US commercial packaging operations is based on the company’s business strategy to focus on growing its world-leading businesses in development solutions and advanced delivery technologies, clinical trial supplies, advanced blow/fill/seal aseptic delivery technology for respiratory, ophthalmic, and other products, as well as offering integrated solutions for the development and supply of injectable biologics and complex pharmaceutical products.
Frazier Healthcare was founded in 1991 to invest exclusively in healthcare, and is a leading provider of growth equity and venture capital to high-growth and emerging healthcare companies.
From drug and biologic development services to delivery technologies to supply solutions, Catalent Pharma Solutions has the deepest expertise, the broadest offerings, and the most unique technologies in the industry. With over 75 years of experience, Catalent helps customers get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and packaging solutions. For more information, visit www.catalent.com.
Total Page Views: 1345
